Nitric oxide-modulating agents for gastrointestinal disorders (Q28192955)

Expert Opinion on Investigational Drugs

Europe PubMed Central

title

Nitric oxide-modulating agents for gastrointestinal disorders (English)

0 references

author name string

Brendan J R Whittle

series ordinal

1

0 references

language of work or name

English

0 references

publication date

November 2005

0 references

published in

0 references

volume

14

0 references

issue

11

0 references

page(s)

1347-58

0 references

cites work

Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Risk assessment of endogenous formation of carcinogenic N-nitroso compounds in response to intake of NO-aspirin

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxide-releasing derivative of mesalamine in rodent colitis

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-kappaB

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.14.11.1347

Nitric oxide in gastrointestinal health and disease

21 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

COX-2 inhibitors--a lesson in unexpected problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Nitric-oxide-donating NSAIDs as agents for cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Nitrates and NO release: contemporary aspects in biological and medicinal chemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

The effects and metabolic fate of nitroflurbiprofen in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Direct gas measurements indicate that the novel cyclooxygenase inhibitor AZD3582 is an effective nitric oxide donor in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Synthesis and selective cyclooxygenase-2 (COX-2) inhibitory activity of a series of novel bicyclic pyrazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Sildenafil: emerging cardiovascular indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

The effect of sildenafil on oesophageal motor function in healthy subjects and patients with nutcracker oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

The effect of sildenafil on gastric emptying in patients with end-stage renal failure and symptoms of gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Selective reversal of hyperglycemia-evoked gastric myoelectric dysrhythmias by nitrergic stimulation in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Manometric study of topical sildenafil (Viagra) in patients with chronic anal fissure: sildenafil reduces anal resting tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Treatment of chronic anal fissure by application of L-arginine gel: a phase II study in 15 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Nitric oxide in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Complexity of inducible nitric oxide synthase: cellular source determines benefit versus toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

N-(3-(aminomethyl)benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Helicobacter pylori lipopolysaccharide-provoked injury to rat gastroduodenal microvasculature involves inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

A novel potent inhibitor of inducible nitric oxide inhibitor, ONO-1714, reduces intestinal ischemia-reperfusion injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Nitrosative stress and pharmacological modulation of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Gastrointestinal effects of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Role of bacteria and inducible nitric oxide synthase activity in the systemic inflammatory microvascular response provoked by indomethacin in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

When saliva meets acid: chemical warfare at the oesophagogastric junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Nitrate, bacteria and human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Nitrite in saliva increases gastric mucosal blood flow and mucus thickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Enhanced anti-inflammatory potency of a nitric oxide-releasing prednisolone derivative in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Synthesis of nitro esters of prednisolone, new compounds combining pharmacological properties of both glucocorticoids and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347

Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.11.1347